117 related articles for article (PubMed ID: 21823034)
41. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
[TBL] [Abstract][Full Text] [Related]
42. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
43. BNP as a biomarker in heart disease.
Vuolteenaho O; Ala-Kopsala M; Ruskoaho H
Adv Clin Chem; 2005; 40():1-36. PubMed ID: 16355919
[TBL] [Abstract][Full Text] [Related]
44. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
Hariu CD; Saunders AB; Gordon SG; Norby B; Miller MW
J Vet Cardiol; 2013 Sep; 15(3):197-204. PubMed ID: 23933478
[TBL] [Abstract][Full Text] [Related]
45. Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction.
Kittiwarawut A; Vorasettakarnkij Y; Tanasanvimon S; Manasnayakorn S; Sriuranpong V
Asia Pac J Clin Oncol; 2013 Jun; 9(2):155-61. PubMed ID: 22897825
[TBL] [Abstract][Full Text] [Related]
46. NT-ProBNP and cardiac troponin I in virulent canine babesiosis.
Lobetti R; Kirberger R; Keller N; Kettner F; Dvir E
Vet Parasitol; 2012 Dec; 190(3-4):333-9. PubMed ID: 22884910
[TBL] [Abstract][Full Text] [Related]
47. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
Couto KM; Iazbik MC; Marín LM; Zaldivar-López S; Beal MJ; Gómez Ochoa P; Couto CG
Vet Clin Pathol; 2015 Sep; 44(3):405-9. PubMed ID: 25982692
[TBL] [Abstract][Full Text] [Related]
48. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Souttar K; Elliott J
J Vet Intern Med; 2012; 26(2):302-11. PubMed ID: 22369312
[TBL] [Abstract][Full Text] [Related]
49. Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.
Ruaux C; Scollan K; Suchodolski JS; Steiner JM; Sisson DD
Vet Clin Pathol; 2015 Sep; 44(3):420-30. PubMed ID: 26108974
[TBL] [Abstract][Full Text] [Related]
50. Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.
Pelander L; Häggström J; Ley CJ; Ljungvall I
J Vet Intern Med; 2017 May; 31(3):805-813. PubMed ID: 28370332
[TBL] [Abstract][Full Text] [Related]
51. Effect of selenium and Q10 on the cardiac biomarker NT-proBNP.
Johansson P; Dahlström Ö; Dahlström U; Alehagen U
Scand Cardiovasc J; 2013 Oct; 47(5):281-8. PubMed ID: 23895165
[TBL] [Abstract][Full Text] [Related]
52. Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity.
Perik PJ; Rikhof B; de Jong FA; Verweij J; Gietema JA; van der Graaf WT
Ann Oncol; 2008 Feb; 19(2):359-61. PubMed ID: 17962203
[TBL] [Abstract][Full Text] [Related]
53. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
Haßdenteufel E; Kresken JG; Henrich E; Hildebrandt N; Schneider C; Stosic A; Schneider M
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):171-9. PubMed ID: 22688794
[TBL] [Abstract][Full Text] [Related]
54. Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation.
Hausken J; Klingenberg O; Mørkrid L; Rollag H; Foss A; Midtvedt K
Transplantation; 2012 Jul; 94(2):e15-6. PubMed ID: 22820562
[No Abstract] [Full Text] [Related]
55. Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation.
Machen MC; Oyama MA; Gordon SG; Rush JE; Achen SE; Stepien RL; Fox PR; Saunders AB; Cunningham SM; Lee PM; Kellihan HB
J Vet Cardiol; 2014 Dec; 16(4):245-55. PubMed ID: 25456274
[TBL] [Abstract][Full Text] [Related]
56. NT-proBNP and cardiac troponin I concentrations in dogs with tick paralysis caused by Ixodes holocyclus.
Nicolson GP; McGrath A; Webster RA; Li J; Kaye S; Malik R; Beijerink NJ
Aust Vet J; 2016 Aug; 94(8):274-9. PubMed ID: 27461350
[TBL] [Abstract][Full Text] [Related]
57. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
Iwanuk N; Nolte I; Wall L; Sehn M; Raue J; Pilgram A; Rumstedt K; Bach JP
BMC Vet Res; 2019 Jul; 15(1):237. PubMed ID: 31288807
[TBL] [Abstract][Full Text] [Related]
58. Correlation between NT-proBNP and lipase levels according to the severity of chronic mitral valve disease in dogs.
Park JS; Park JH; Seo KW; Song KH
J Vet Sci; 2019 Jul; 20(4):e43. PubMed ID: 31364327
[TBL] [Abstract][Full Text] [Related]
59. Basal plasma concentrations of N-terminal pro-B-type natriuretic peptide in clinically healthy adult small size dogs: effect of body weight, age, gender and breed, and reference intervals.
Misbach C; Chetboul V; Concordet D; Gruet P; Speranza C; Hoffmann AC; Rocha A; Balouka D; Petit AM; Trehiou-Sechi E; Pouchelon JL; Lefebvre HP
Res Vet Sci; 2013 Dec; 95(3):879-85. PubMed ID: 23993661
[TBL] [Abstract][Full Text] [Related]
60. NT-proBNP concentrations in mountain marathoners.
Banfi G; Lippi G; Susta D; Barassi A; D'Eril GM; Dogliotti G; Corsi MM
J Strength Cond Res; 2010 May; 24(5):1369-72. PubMed ID: 20393354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
